000 | 01466 a2200361 4500 | ||
---|---|---|---|
005 | 20250517224244.0 | ||
264 | 0 | _c20190225 | |
008 | 201902s 0 0 eng d | ||
022 | _a1535-3699 | ||
024 | 7 |
_a10.1177/1535370218785152 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhou, Weinan | |
245 | 0 | 0 |
_aInsulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans. _h[electronic resource] |
260 |
_bExperimental biology and medicine (Maywood, N.J.) _c07 2018 |
||
300 |
_a911-916 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
650 | 0 | 4 |
_aIntestinal Mucosa _xdrug effects |
650 | 0 | 4 |
_aObesity _xpathology |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinase _xmetabolism |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aStem Cells _xdrug effects |
700 | 1 | _aRowitz, Blair M | |
700 | 1 | _aDailey, Megan J | |
773 | 0 |
_tExperimental biology and medicine (Maywood, N.J.) _gvol. 243 _gno. 11 _gp. 911-916 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1535370218785152 _zAvailable from publisher's website |
999 |
_c28576766 _d28576766 |